Evidence map›Paper›PMID 25031761›Full record

ReviewInternational journal of clinical and experimental pathology2014

Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-CHOP therapy and intrathecal administration: a case report and review of literature.

Yasunobu Sekiguchi, Asami Shimada, Hidenori Imai, Mutsumi Wakabayashi, Keiji Sugimoto, Noriko Nakamura, Tomohiro Sawada, Norio Komatsu, Masaaki Noguchi

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Intravascular Lymphoma in the CNS: Options for Treatment.Current treatment options in neurology · 2017
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yasunobu SekiguchiDepartment of Hematology, Juntendo University Urayasu Hospital Japan.
Asami ShimadaDepartment of Hematology, Juntendo University Urayasu Hospital Japan.
Hidenori ImaiShibanishi Clinic Japan.
Mutsumi WakabayashiDepartment of Hematology, Juntendo University Urayasu Hospital Japan.
Keiji SugimotoDepartment of Hematology, Juntendo University Urayasu Hospital Japan.
Noriko NakamuraDepartment of Clinical Laboratory, Juntendo University Urayasu Hospital Japan.
Tomohiro SawadaDepartment of Clinical Laboratory, Juntendo University Urayasu Hospital Japan.
Norio KomatsuDepartment of Hematology, Juntendo University Hospital Japan.
Masaaki NoguchiDepartment of Hematology, Juntendo University Urayasu Hospital Japan.
Juntendo University Urayasu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 46-year-old man developed a fever and cough, and computed tomography showed multiple, nodular infiltrative shadows in lungs. He was diagnosed as having intravascular large B-cell lymphoma (IVLBCL). Brain magnetic resonance imaging (MRI, T2W1) showed an abnormal signal area in the pons, which was IVLBCL involvement. R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) therapy and intrathecal (I.T.) injection of methotrexate, cytarabine and prednisolone were selected. Complete remission (CR) was achieved and pontine involvement disappeared. A total of 8 courses of R-CHOP therapy and 4 courses of I.T. were performed. CR has been maintained for 1 year and 2 months.

Indexed as

Antibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsBrain NeoplasmsCyclophosphamideCytarabineDoxorubicinHumansInjections, SpinalLung NeoplasmsLymphoma, B-CellMaleMethotrexateMiddle AgedPonsPrednisolonePrednisoneAntibodies, Monoclonal, Murine-DerivedCyclophosphamideCytarabineDoxorubicinMethotrexatePrednisolonePrednisoneR-CHOP protocolRituximabVincristinecentral nervous system involvementCHOP therapyintrathecal administrationIntravascular large B-cell lymphomarituximab

Identifiers

PMID25031761
PMCPMC4097275
OpenAlexW2265201629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.